Iter-4360dd15-0072-transcript
第 72 轮执行轨迹
→ call search_memory({"limit":8,"query":"4360dd15 NEXT_FOCUS audit table synonym mapping longevity proxy feasibility PMID 33977284 29408453"})【tool:search_memory】
{"ok": true, "results": [{"title": "Iter-4360dd15-0060-transcript", "tags": "iteration transcript", "modified": "20260424200117000", "preview": "!! 第 60 轮执行轨迹
→"}, {"title": "Iter-4360dd15-0071-transcript", "tags": "iteration transcript", "modified": "20260424201853000", "preview": "!! 第 71 轮执行轨迹 → call search_memory({\"limit\":10,\"query\":\"4360dd15 NEXT_FOCUS 剩余 10 条候选 PMID 研究类型 保留 排除 理由 extension follow-up secondary analysis\"}) → call list_recent({\"n\":8}) → call list_by_tag({\"limit\":20,\"tag\":\"4360dd15 → call list_recent({"n":8})
→ call list_by_tag({"limit":20,"tag":"4360dd15"})
→ call list_tools({})
【tool:list_recent】
{"ok": true, "items": [{"title": "Iter-4360dd15-0071-reflection", "modified": "20260424201859000", "tags": "iteration reflection"}, {"title": "NEXT_FOCUS", "modified": "20260424201859000", "tags": "pinned focus"}, {"title": "先抽字段再定规则", "modified": "20260424201859000", "tags": "lesson audit endpoint-extraction synonym-mapping"}, {"title": "Iter-4360dd15-0071-transcript", "modified": "20260424201853000", "tags": "iteration transcript"}, {"title": "Iter-4360dd15-0071-minimal-audit-rules", "modified": "20260424201843000", "tags": "4360dd15 knowledge method"}, {"title": "Iter-4360dd15-0070-reflection", "modified": "20260424201631000", "tags": "iteration reflection"}, {"title": "先表格化再抽象规则", "modified": "20260424201631000", "tags": "lesson tooling audit extraction"}, {"title": "Iter-4360dd15-0070-transcript", "modified": "20260424201625000", "tags": "iteration transcript"}]}
【tool:list_by_tag】
{"ok": true, "items": [{"title": "Iter-4360dd15-0071-minimal-audit-rules", "modified": "20260424201843000"}, {"title": "Iter-4360dd15-0069-standardized-audit-table-two-trials", "modified": "20260424201621000"}, {"title": "Iter-4360dd15-0068-abstract-endpoint-extraction", "modified": "20260424201407000"}, {"title": "Iter-4360dd15-0067-abstract-endpoints-aging-criteria", "modified": "20260424201141000"}, {"title": "Iter-4360dd15-0066-TierA-abstracts-and-endpoints-for-aging-criteria", "modified": "20260424200925000"}, {"title": "Iter-4360dd15-0065-minimal-relevance-decision-rules-for-retained-mtor-trials", "modified": "20260424200748000"}, {"title": "Iter-4360dd15-0064-relevance-tiering-10-pmids", "modified": "20260424200602000"}, {"title": "Iter-4360dd15-0063-10-pmid-audit-table", "modified": "20260424200432000"}, {"title": "Iter-4360dd15-0062-pubmed-title-verification-10-pmids", "modified": "20260424200328000"}, {"title": "Iter-4360dd15-0061-candidate-audit-10-remaining-pmids", "modified": "20260424200221000"}, {"title": "PMID 38310895 is a review, not a primary trial", "modified": "20260424200109000"}, {"title": "PMID 35040506 longitudinal analysis is embedded in primary trial", "modified": "20260424195939000"}, {"title": "Iter-4360dd15-0058-longevity-evidence-proximity-tagging", "modified": "20260424195827000"}, {"title": "Iter-4360dd15-0057-study-design-taxonomy-for-retained-trials", "modified": "20260424195711000"}, {"title": "Iter-4360dd15-0056-pubmed-boundary-confirmatio
【tool:list_tools】
{"ok": true, "tools": [{"name": "search_memory", "description": "在 TiddlyWiki 长期记忆中按关键字搜索（支持中文空格分隔），返回标题、标签、预览。每轮迭代开始前应先调用以回忆。", "custom": false}, {"name": "read_note", "description": "读取某一条 tiddler 的完整正文。", "custom": false}, {"name": "write_note", "description": "向 TiddlyWiki 写入（或覆盖）一条 tiddler。这是 Sisyphus 的长期记忆入口——每轮至少写一条。建议标签：knowledge, experiment, reflection, plan, idea, fact, question, lesson。TiddlyWiki 标记：!! 小标题，''粗体''，//斜体//，[[其它tiddler]]。", "custom": false}, {"name": "list_recent", "description": "列出最近修改过的 tiddler。", "custom": false}, {"name": "list_by_tag", "description": "按标签列出相关 tiddler。", "custom": false}, {"name": "run_python", "description": "在 workspace/ 下以子进程执行一段 Python 代码，返回 stdout/stderr。用于计算、模拟、验证假设、抓取公开数据（禁止任何破坏性操作）。", "custom": false}, {"name": "read_file", "description": "读取 workspace/ 下的某个文件。", "custom": false}, {"name": "write_file", "description": "向 workspace/ 下写入文件（默认覆盖，append=true 时追加）。", "custom": false}, {"name": "list_files", "description": "列出 workspace/ 下的文件。", "custom": false}, {"name": "web_fetch", "description": "抓取任意公开 URL（GET），返回剥离 HTML 后的纯文本。适合读论文摘要、文档、博客、百科。", "custom": false}, {"name": "web_search", "description": "用 DuckDuckGo 搜索互联网，返回 title/url/snippet 列表。找入口、找链接、调研时用。", "custom": false}, {"name": "wiki_search", "description": "维基百科搜索：返回若干条目的摘要和 URL。lang 默认 en，可传 zh 等。", "custom": false}, {"name": "arxiv_search", "description": "arXiv 论文检索：标题/作者/摘要/链接。理论、数学、物理、CS、bio 类前沿论文的主入口。", "custom": false}, {"name": "pubmed_search", "descriptio
→ call read_note({"title":"Iter-4360dd15-0071-minimal-audit-rules"})
→ call read_note({"title":"Iter-4360dd15-0069-standardized-audit-table-two-trials"})
→ call read_note({"title":"Iter-4360dd15-0068-abstract-endpoint-extraction"})
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0071-minimal-audit-rules", "tags": "4360dd15 knowledge method", "text": "!! 第 71 轮：摘要抽取字段、同义词映射与最小判定规则（批量版）\n\n本轮把两篇 Tier A 试验（PMID 33977284、PMID 29408453）的人工审计经验压缩成可批量应用的最小规则集。\n\n!! 建议抽取字段\n1. PMID\n2. 题名\n3. 研究类型（RCT / phase / pilot / feasibility）\n4. 年龄判据（age cutoff / older adults / older human cohort）\n5. 干预与对照\n6. 主要终点（primary outcome / primary endpoint / main endpoint）\n7. 终点域（survival / morbidity / infection / biomarker / function / safety）\n8. 分类标签（longevity / proxy / feasibility）\n9. 证据来源（abstract / PMC / Europe PMC）\n\n!! 同义词映射（最小集合）\n- 年龄判据：\n - ''older adults''\n - ''aged at least''\n - ''older human cohort''\n - ''generally healthy older adults''\n - ''elderly''\n- longevity 词：\n - ''lifespan'' / ''life extension'' / ''survival'' / ''mortality'' / ''all-cause mortality'' / ''disease-free survival'' / ''event-free survival'' / ''time to death''\n- proxy 词：\n - ''infection incidence'' / ''RTIs'' / ''respiratory illness'' / ''immune function'' / ''IFN-induced antiviral gene expression''\n - ''cognitive'' / ''physical performance'' / ''handgrip strength'' / ''timed walks'' / ''cytokines'' / ''blood cell subsets'' / ''biomarker''\n- feasibility 词：\n - ''feasibility'' / ''safety'' / ''tolerability'' / ''pilot'' / ''proof-of-concept'' / ''establish the feasibility''\n\n!! 最小判定规则\n- 若标题/摘要明确出现 feasibility/safety/tolerability/pilot/proof-of-concept，则优先判为 //feasibility/safety pilot//。\n- 否则若主要终点明确是 survival / mortality / lifes
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0069-standardized-audit-table-two-trials", "tags": "4360dd15 knowledge fact method", "text": "!! 第 70 轮：两篇 Tier A 试验的标准化审计表\n\n本轮子任务：把 PMID 33977284 与 PMID 29408453 的摘要/可访问全文中“主要终点 / 年龄判据”压缩成一个可复用的审计表，便于后续批量筛查与分层。\n\n| PMID | 研究题名 | 研究类型 | 年龄判据 / 入组人群 | 主要终点（primary outcome / main endpoint） | 最直接的衰老相关判据 | 审计分类 |\n|---|---|---|---|---|---|---|\n| 33977284 | Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials | phase 2b + phase 3 randomized controlled trials | adults aged at least 65 years；phase 2b 进一步限定 65–85 岁且有慢病/吸烟等风险背景 | phase 2b：16 周冬季冷/流感季的 //laboratory-confirmed RTIs// 发生率；phase 3：//clinically symptomatic respiratory illness// 发生率 | older adults + IFN-induced antiviral gene expression；结局层的 aging proxy 是呼吸道感染负担下降 | //immune-aging / infection-proxy evidence//，不是 longevity endpoint |\n| 29408453 | A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, Physical Performance, and Cognitive Effects | randomized control trial / feasibility pilot | generally healthy older adults aged 70–95 years | 摘要主线是 //feasibility and safety//；主要监测域包括 CBC/CMP/HbA1c/OGTT、认知（EXIT25/SLUMS/TAPS）、体能（handgrip strength、40-foot timed walks）、免疫衰老（cytokines、blood cell subsets） | older adults + cognition/physical performance/inflammation/immune-cell subsets | //geroprotector feasibility/safety pilot//，不是硬终点抗衰老
【tool:read_note】
{"ok": true, "title": "Iter-4360dd15-0068-abstract-endpoint-extraction", "tags": "4360dd15 knowledge fact method", "text": "!! 第 68 轮：从 PMC 可访问全文抽取两篇试验的 primary outcome 与直接衰老判据\n\n本轮子任务：只做一件事——把 PMID 33977284 与 PMID 29408453 的 //primary outcome// 和最直接的衰老相关判据从可访问全文中定位出来，作为后续审计的可复用证据。\n\n!! PMID 33977284\n'''题名'''：Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials\n\n'''可验证的 primary outcome'''\n- phase 2b primary outcome = 16 周冬季流感/感冒季期间 //laboratory-confirmed RTIs// 的发生率。\n- phase 3 primary outcome = //clinically symptomatic respiratory illness// 的发生率（无论是否实验室确认）。\n\n'''最直接的衰老相关判据'''\n- 纳入标准：''adults aged at least 65 years''。\n- 生物学 aging proxy：IFN-induced antiviral gene expression 的上调。\n- 结果层 aging proxy：RTI 易感性 / 感染负担是否下降。\n- 该试验没有把寿命或疾病自由生存作为终点，因此只能归为 //immune-aging / infection-proxy evidence//，不能夸大为 longevity endpoint。\n\n'''可访问来源'''\n- PMC：https://pmc.ncbi.nlm.nih.gov/articles/PMC8102040/\n- PMID：33977284\n\n!! PMID 29408453\n'''题名'''：A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects\n\n'''可验证的 primary endpoint / 研究主线'''\n- 摘要明确指向 //feasibility and safety//。\n- 监测的主要结果域包括：CBC/CMP/HbA1c/OGTT；认知（EXIT25、SLUMS、TAPS）；体能（handgrip strength、40-foot timed walks）；免疫衰老（pro-inflammatory cytokines、blood cell subsets）。\n\n'''最直接的衰老相关判据'''\n- 纳入对象：''generally healthy older adults (
→ call pubmed_search({"limit":3,"query":"33977284"})
→ call pubmed_search({"limit":3,"query":"29408453"})
→ call pubmed_search({"limit":3,"query":"38310895"})
【tool:pubmed_search】
{"ok": true, "query": "33977284", "results": [{"pmid": "33977284", "title": "Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.", "source": "Lancet Healthy Longev", "pubdate": "2021 May", "authors": ["Mannick JB", "Teo G", "Bernardo P", "Quinn D", "Russell K", "Klickstein L", "Marshall W", "Shergill S"], "url": "https://pubmed.ncbi.nlm.nih.gov/33977284/"}]}
【tool:pubmed_search】
{"ok": true, "query": "29408453", "results": [{"pmid": "29408453", "title": "A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.", "source": "Exp Gerontol", "pubdate": "2018 May", "authors": ["Kraig E", "Linehan LA", "Liang H", "Romo TQ", "Liu Q", "Wu Y", "Benavides AD", "Curiel TJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/29408453/"}]}
【tool:pubmed_search】
{"ok": true, "query": "38310895", "results": [{"pmid": "38310895", "title": "Targeting ageing with rapamycin and its derivatives in humans: a systematic review.", "source": "Lancet Healthy Longev", "pubdate": "2024 Feb", "authors": ["Lee DJW", "Hodzic Kuerec A", "Maier AB"], "url": "https://pubmed.ncbi.nlm.nih.gov/38310895/"}]}
→ call web_fetch({"max_chars":5000,"url":"https://pubmed.ncbi.nlm.nih.gov/33977284/"})
→ call web_fetch({"max_chars":5000,"url":"https://pubmed.ncbi.nlm.nih.gov/29408453/"})
→ call web_fetch({"max_chars":5000,"url":"https://pubmed.ncbi.nlm.nih.gov/38310895/"})
【tool:web_fetch】
{"ok": false, "error": "Client error '403 Forbidden' for url 'https://pubmed.ncbi.nlm.nih.gov/33977284/'\nFor more information check: https://developer.mozilla.org/en-US/docs/Web/HTTP/Status/403"}
【tool:web_fetch】
{"ok": false, "error": "Client error '403 Forbidden' for url 'https://pubmed.ncbi.nlm.nih.gov/29408453/'\nFor more information check: https://developer.mozilla.org/en-US/docs/Web/HTTP/Status/403"}
【tool:web_fetch】
{"ok": false, "error": "Client error '403 Forbidden' for url 'https://pubmed.ncbi.nlm.nih.gov/38310895/'\nFor more information check: https://developer.mozilla.org/en-US/docs/Web/HTTP/Status/403"}
→ call run_python({"code":"import requests, re, xml.etree.ElementTree as ET\npmids=['33977284','29408453','38310895']\nfor pmid in pmids:\n url=f'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id={pmid}&retmode=xml'\n r=requests.get(url,timeout=20)\n print('PMID',pmid,'status',r.status_code,'len',len(r.text))\n print(r.text[:500].replace('\\n',' ')[:500])\n print('---')\n","timeo)
【tool:run_python】
{"ok": true, "stdout": "PMID 33977284 status 200 len 19988\n<?xml version=\"1.0\" ?> <!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\"> <PubmedArticleSet> <PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\"><PMID Version=\"1\">33977284</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Jour\n---\nPMID 29408453 status 200 len 40027\n<?xml version=\"1.0\" ?> <!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\"> <PubmedArticleSet> <PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Manual\"><PMID Version=\"1\">29408453</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journ\n---\nPMID 38310895 status 200 len 6090\n<?xml version=\"1.0\" ?> <!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\"> <PubmedArticleSet> <PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\"><PMID Version=\"1\">38310895</PMID><Da
→ call run_python({"code":"import requests, xml.etree.ElementTree as ET, re, json\npmids=['33977284','29408453','38310895']\nNS=''\n\ndef fetch(pmid):\n url=f'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id={pmid}&retmode=xml'\n xml=requests.get(url,timeout=20).text\n root=ET.fromstring(xml)\n art=root.find('.//PubmedArticle')\n title=' '.join(art.findtext('.//ArticleTitle', de)
【tool:run_python】
{"ok": true, "stdout": "omly assigned to using a validated automated randomisation system to oral RTB101 5 mg, RTB101 10 mg once daily, or placebo in part 1 and RTB101 10 mg once daily, RTB101 10 mg twice daily, RTB101 10 mg plus everolimus once daily, \nMESH sample: ['Aged', 'Aging', 'Antiviral Agents', 'Biology', 'COVID-19', 'Diabetes Mellitus, Type 2', 'Everolimus', 'Humans', 'Immunity', 'MTOR Inhibitors', 'Pandemics', 'Pulmonary Disease, Chronic Obstructive']\n\nPMID 29408453\nTITLE: A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.\nPUB_TYPES: ['Clinical Trial, Phase II', 'Journal Article', 'Randomized Controlled Trial', 'Research Support, N.I.H., Extramural', \"Research Support, Non-U.S. Gov't\"]\nABSTRACT: Inhibition of the mechanistic target of rapamycin (mTOR) pathway by rapamycin (RAPA), an FDA-approved immunosuppressive drug used as a clinical therapy to prevent solid organ allograft rejection, enhances longevity in mice. Importantly, RAPA was efficacious even when initiated in relatively old animals, suggesting that mTOR inhibition could potentially slow the progression of aging-associated pathologies in older humans (Harrison et al., 2009; Miller et al., 2011). However, the safety and tolerability of RAPA in older human subjects have not yet been demonstrated. Towards this end, we undertook a placebo-controlled pilot study in 25 generally
→ call define_tool({"name":"pubmed_trial_audit_classifier","description":"Fetch PubMed XML for PMIDs and classify each record into longevity / proxy / feasibility / review-exclusion using the current mission's minimal audit rules. Returns structured fields useful for batch screening.","code":"import re, json, requests, xml.etree.ElementTree as ET\n\nLONGLIFE = [\n 'lifespan', 'life extension', 'survival', 'mortal)
【tool:define_tool】
{"ok": false, "error": "参数错误: tool_define_tool() missing 1 required positional argument: 'parameters'"}
→ call run_python({"code":"import requests, xml.etree.ElementTree as ET, re, json\npmids=['33977284','29408453','38310895']\nreview_hit=[]\nfor pmid in pmids:\n xml=requests.get(f'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id={pmid}&retmode=xml',timeout=20).text\n root=ET.fromstring(xml)\n art=root.find('.//PubmedArticle')\n title=' '.join(art.findtext('.//ArticleTitle', default)
【tool:run_python】
{"ok": true, "stdout": "[\n {\n \"pmid\": \"33977284\",\n \"title\": \"Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials.\",\n \"pub_types\": [\n \"Clinical Trial, Phase II\",\n \"Clinical Trial, Phase III\",\n \"Journal Article\",\n \"Randomized Controlled Trial\",\n \"Research Support, N.I.H., Extramural\"\n ],\n \"is_review\": false\n },\n {\n \"pmid\": \"29408453\",\n \"title\": \"A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.\",\n \"pub_types\": [\n \"Clinical Trial, Phase II\",\n \"Journal Article\",\n \"Randomized Controlled Trial\",\n \"Research Support, N.I.H., Extramural\",\n \"Research Support, Non-U.S. Gov't\"\n ],\n \"is_review\": false\n },\n {\n \"pmid\": \"38310895\",\n \"title\": \"Targeting ageing with rapamycin and its derivatives in humans: a systematic review.\",\n \"pub_types\": [\n \"Systematic Review\",\n \"Journal Article\",\n \"Research Support, Non-U.S. Gov't\"\n ],\n \"is_review\": true\n }\n]\n", "stderr": "", "returncode": 0}
→ call write_note({"tags":["4360dd15","knowledge","method"],"text":"!! 第 72 轮：批量审计时应先做 review-exclusion，再做 longevity/proxy/feasibility 分类\n\n本轮用 PubMed XML 复核了 3 个关键 PMID，并得到一个可直接批量化的新增规则：\n\n!! 新增最小规则\n- 若 `PublicationType` 含 ''Systematic Review''，或题名/摘要含 ''review'' / ''meta-analysis''，应先判为 //review-exclusion//，不要继续把它归入 longevity / proxy / feasibility 证据。\n- 这条规则的优先级应高于现有三分法：\n ''review-exclusion'' > ''feasibilit)
【tool:write_note】
{"ok": true, "path": "C:\\Users\\yh599\\Documents\\GitHub\\LLM-yh\\Sisyphus\\wiki\\tiddlers\\Iter-4360dd15-0072-review-exclusion-first-rule.tid", "title": "Iter-4360dd15-0072-review-exclusion-first-rule"}
【assistant】
第 72 轮我做了一个很窄但有用的升级：**给批量审计新增了“review-exclusion 优先门禁”**。
### 本轮动作
- 复核了 3 个 PMID 的 PubMed XML：
- **33977284**：不是 review，维持为 **aging-proxy evidence**
- **29408453**：不是 review，维持为 **feasibility/safety pilot**
- **38310895**：明确是 **Systematic Review**，应先排除出 primary-trial 证据集
- 由此把规则顺序收紧为：
- **review-exclusion > feasibility/safety pilot > longevity endpoint > aging-proxy evidence**
### 沉淀
- 已写入长期记忆：
- `Iter-4360dd15-0072-review-exclusion-first-rule`
### 这轮的新东西
- 不是重复旧分类，而是补了一个**更上游的门禁规则**：
先剥离综述，再做三分法分类，这样批量筛选不会把综述误当原始试验。
<NEXT_FOCUS>下一轮最值得做的是：把“review-exclusion”规则扩展成可批量执行的最小 PubMed XML 解析模板（PublicationType + 题名关键词 + 摘要关键词）。</NEXT_FOCUS>